NYSE:COR

Cencora (COR) Stock Price, News & Analysis

$224.60
+0.51 (+0.23%)
(As of 05/10/2024 ET)
Today's Range
$224.02
$225.67
50-Day Range
$224.00
$245.77
52-Week Range
$163.37
$246.75
Volume
943,908 shs
Average Volume
1.55 million shs
Market Capitalization
$44.80 billion
P/E Ratio
24.57
Dividend Yield
0.91%
Price Target
$233.90

Cencora MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.70 Rating Score
Upside/​Downside
4.1% Upside
$233.90 Price Target
Short Interest
Bearish
4.88% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-0.77
Upright™ Environmental Score
News Sentiment
0.14mentions of Cencora in the last 14 days
Based on 11 Articles This Week
Insider Trading
Selling Shares
$18 M Sold Last Quarter
Proj. Earnings Growth
9.45%
From $13.44 to $14.71 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.95 out of 5 stars

Medical Sector

198th out of 925 stocks

Drugs, Proprietaries, & Sundries Industry

4th out of 7 stocks

COR stock logo

About Cencora Stock (NYSE:COR)

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

COR Stock Price History

COR Stock News Headlines

Shocking $16T Elon Musk Crypto Leak
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.
Shocking $16T Elon Musk Crypto Leak
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.
Cencora (NYSE:COR) Price Target Raised to $277.00
Cencora (NYSE:COR) Downgraded by StockNews.com to Buy
Cencora Outperforms in Q2: A Buy Rating with Room to Grow
See More Headlines
Receive COR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cencora and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 2/26 Dividend
2/08/2024
Dividend Payable
2/26/2024
Last Earnings
5/01/2024
Ex-Dividend for 5/24 Dividend
5/09/2024
Today
5/11/2024
Dividend Payable
5/24/2024
Next Earnings (Estimated)
8/07/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drugs, proprietaries, & sundries
Sub-Industry
Health Care Distributors
CUSIP
03073E10
Employees
46,000
Year Founded
2001

Price Target and Rating

Average Stock Price Target
$233.90
High Stock Price Target
$280.00
Low Stock Price Target
$190.00
Potential Upside/Downside
+4.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.70
Research Coverage
10 Analysts

Profitability

Net Income
$1.75 billion
Pretax Margin
0.83%

Debt

Sales & Book Value

Annual Sales
$262.17 billion
Cash Flow
$17.13 per share
Book Value
$6.15 per share

Miscellaneous

Free Float
167,964,000
Market Cap
$44.80 billion
Optionable
Optionable
Beta
0.47

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

COR Stock Analysis - Frequently Asked Questions

Should I buy or sell Cencora stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cencora in the last twelve months. There are currently 3 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" COR shares.
View COR analyst ratings
or view top-rated stocks.

What is Cencora's stock price target for 2024?

10 brokerages have issued 12-month price targets for Cencora's stock. Their COR share price targets range from $190.00 to $280.00. On average, they predict the company's share price to reach $233.90 in the next year. This suggests a possible upside of 4.1% from the stock's current price.
View analysts price targets for COR
or view top-rated stocks among Wall Street analysts.

How have COR shares performed in 2024?

Cencora's stock was trading at $205.38 at the beginning of the year. Since then, COR stock has increased by 9.4% and is now trading at $224.60.
View the best growth stocks for 2024 here
.

When is Cencora's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 7th 2024.
View our COR earnings forecast
.

How were Cencora's earnings last quarter?

Cencora, Inc. (NYSE:COR) released its earnings results on Wednesday, May, 1st. The company reported $3.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.65 by $0.15. The business earned $68.41 billion during the quarter, compared to analyst estimates of $70.60 billion. Cencora had a net margin of 0.67% and a trailing twelve-month return on equity of 268.67%. The business's revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter last year, the firm earned $3.50 earnings per share.

How often does Cencora pay dividends? What is the dividend yield for Cencora?

Cencora declared a quarterly dividend on Thursday, May 2nd. Investors of record on Friday, May 10th will be given a dividend of $0.51 per share on Friday, May 24th. This represents a $2.04 dividend on an annualized basis and a dividend yield of 0.91%. The ex-dividend date is Thursday, May 9th.
Read our dividend analysis for COR
.

Is Cencora a good dividend stock?

Cencora (NYSE:COR) pays an annual dividend of $2.04 per share and currently has a dividend yield of 0.91%. The company has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 22.32%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, COR will have a dividend payout ratio of 13.87% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for COR.

What guidance has Cencora issued on next quarter's earnings?

Cencora issued an update on its FY24 earnings guidance on Wednesday, May, 1st. The company provided earnings per share (EPS) guidance of $13.30-13.50 for the period, compared to the consensus earnings per share estimate of $13.45.

What is Paul E. Szurek's approval rating as Cencora's CEO?

27 employees have rated Cencora Chief Executive Officer Paul E. Szurek on Glassdoor.com. Paul E. Szurek has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Cencora own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cencora investors own include Digital Realty Trust (DLR), NVIDIA (NVDA), Cisco Systems (CSCO), AbbVie (ABBV), Crown Castle (CCI), AT&T (T), Intel (INTC), Realty Income (O), QUALCOMM (QCOM) and Enterprise Products Partners (EPD).

Who are Cencora's major shareholders?

Cencora's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (10.20%), JPMorgan Chase & Co. (2.48%), Mizuho Markets Americas LLC (0.00%), Bank of New York Mellon Corp (0.60%), Sumitomo Mitsui Trust Holdings Inc. (0.49%) and Coho Partners Ltd. (0.43%). Insiders that own company stock include Elizabeth S Campbell, Gina Clark, Gina Clark, John G Chou, John G Chou, Lazarus Krikorian, Leslie E Donato, Leslie E Donato, Robert P Mauch, Robert P Mauch, Silvana Battaglia, Steven H Collis and Walgreens Boots Alliance, Inc.
View institutional ownership trends
.

How do I buy shares of Cencora?

Shares of COR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Cencora have any subsidiaries?
The following companies are subsidiares of Cencora: AB Singapore Investments Pte Ltd, AB UK Holdings Ltd, ASD Specialty Healthcare LLC, Access M.D., Alliance Healthcare, Amerisource Receivables Financial Corporation, AmerisourceBergen Drug Corporation, AmerisourceBergen Global Holdings GmbH, AmerisourceBergen Global Manufacturer Services GmbH, AmerisourceBergen Group GmbH, AmerisourceBergen International Holdings Inc., AmerisourceBergen Luxembourg S.a.r.L., AmerisourceBergen Services Corporation, AmerisourceBergen Sourcing LLC, AmerisourceBergen Specialty Group LLC, Anderson Packaging, AutoMed Technologies, BPL Group LLC, BPLH Ireland Unlimited Company, Bellco Health, Brecon Pharmaceuticals, Bridge Medical Inc, CD Smith Healthcare, H. D. Smith, IgG America, International Physician Networks L.L.C., IntrinsiQ, Lash Group, MWI Veterinary Supply, Network for Medical Communications & Research, PMSI, PharMEDium Healthcare, Pharmacy Healthcare Solutions, Premier Source, St. Francis Group, Trent Drug, US Bioservices, Wight Nederland Holdco 2 BV, World Courier, World Courier Group S.à r.l., and Xcenda.
Read More
This page (NYSE:COR) was last updated on 5/12/2024 by MarketBeat.com Staff

From Our Partners